HIMS
Another lawyer, same vibe
Pomerantz LLP said it’s investigating claims on behalf of investors in Hims & Hers Health. Translation: the legal headlights are still pointed straight at HIMS, and nobody’s turning them off anytime soon.
Why you should care
When a company keeps popping up in investor investigations, the market starts wondering whether the bad news is a one-off or the opening act. That can pressure sentiment, invite more lawsuits, and make every future update feel like it comes with a tiny asterisk.
The setup
This is one of those headlines that doesn’t come with a revenue number or a product launch — just a reminder that legal overhangs can be sticky. For Hims shareholders, that means the stock may keep trading with an extra dose of drama until the dust settles.
Big picture: Sometimes the business story is great, but the courtroom sequel refuses to end.